{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:12:27Z","timestamp":1787501547471,"version":"build-2736575974"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"State of Kentucky Cabinet for Health and Family Services","award":["PON2_746_244842"],"award-info":[{"award-number":["PON2_746_244842"]}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) is the leading cause of cervical cancer in the United States (U.S.), yet HPV vaccination coverage remains suboptimal and uneven across states. Policy approaches to improve HPV vaccine uptake vary widely across states in terms of health financing, provider authority, school requirements, and consent requirements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive review of state-level HPV vaccination policies was conducted. Information was identified through peer-reviewed literature (PubMed, Scopus, Google Scholar) and authoritative policy and legislative sources, including the Centers for Disease Control and Prevention, National Alliance of State Pharmacy Associations, National Academy for State Health Policy, and state statutes. Policies were categorized into macro-level health policies (Medicaid expansion, pharmacy and pharmacist authority, and state vaccine purchase programs) and HPV-specific policies (school-entry requirements, classroom sex education mandates, parental education mandates, minor consent laws, and exemption frameworks). Evidence on policy implementation and effectiveness was narratively synthesized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Substantial heterogeneity in HPV vaccination policy adoption and implementation across U.S. states was documented. Medicaid expansion, pharmacist vaccination authority, and well-enforced school-entry requirements were consistently associated with higher HPV vaccine initiation or completion, while policies with permissive exemptions or weak enforcement demonstrated limited impact. Financing mechanisms such as universal and selective vaccine purchase programs reduced cost barriers but showed inconsistent effects on uptake when implemented in isolation. Evidence suggests that no single policy is sufficient; multi-level, coordinated policy environments yield the greatest improvements in vaccination coverage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HPV vaccination uptake in the U.S. is shaped by complex and interacting policy mechanisms rather than individual interventions. Integrated policy approaches that combine financing, access expansion, school-based strategies, provider engagement, and enforcement structures are most likely to achieve sustained and equitable improvements in HPV vaccine uptake.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1810845","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:51:52Z","timestamp":1776703912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A comprehensive review of HPV vaccination policies in the United States"],"prefix":"10.3389","volume":"14","author":[{"given":"Yathreb Bayan","family":"Mohamed","sequence":"first","affiliation":[{"name":"Department of Health Management and Systems Sciences, University of Louisville","place":["Louisville, KY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed M.","family":"Karimi","sequence":"additional","affiliation":[{"name":"Department of Health Management and Systems Sciences, University of Louisville","place":["Louisville, KY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"ref1","volume-title":"About HPV","year":"2024"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/OLQ.0000000000001356","article-title":"Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States","volume":"48","author":"Lewis","year":"2021","journal-title":"Sex Transm Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2147\/IJWH.S50365","article-title":"Long-term efficacy and safety of human papillomavirus vaccination","volume":"6","author":"De Vincenzo","year":"2014","journal-title":"Int J Women's Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1188\/06.CJON.559-560","article-title":"Gardasil: introducing the new human papillomavirus vaccine","volume":"10","author":"McLemore","year":"2006","journal-title":"Clin J Oncol Nurs"},{"key":"ref5","first-page":"426","article-title":"Immunization in the United States: recommendations, barriers, and measures to improve compliance: part 1: childhood vaccinations","volume":"41","author":"Ventola","year":"2016","journal-title":"P T"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.15585\/mmwr.mm6733a1","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years\u2014United States, 2017","volume":"67","author":"Walker","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.amepre.2010.01.018","article-title":"Geographic disparity, area poverty, and human papillomavirus vaccination","volume":"38","author":"Pruitt","year":"2010","journal-title":"Am J Prev Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1080\/21645515.2019.1627817","article-title":"State statutes and regulations related to human papillomavirus vaccination","volume":"15","author":"Hoss","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"ref9","first-page":"30","volume-title":"Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older \u2014 United States, 2025","author":"Wodi","year":"2025"},{"key":"ref10","volume-title":"BULLETIN 2025\u201314 (Chaptered Assembly Bill 144 and Coverage of Preventive Care Services)","year":"2025"},{"key":"ref11","year":"2026"},{"key":"ref12","volume-title":"Status of State Action on the Medicaid Expansion Decision: Kaiser Family Foundation","year":"2025"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e0144429","DOI":"10.1371\/journal.pone.0144429","article-title":"Health-related outcomes among the poor: Medicaid expansion vs. non-expansion states","volume":"10","author":"Han","year":"2015","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.1016\/j.vaccine.2020.07.024","article-title":"The association between state Medicaid expansion and human papillomavirus vaccination","volume":"38","author":"Hoff","year":"2020","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1086\/713037","article-title":"Insurance coverage, provider contact, and take-up of the HPV vaccine","volume":"7","author":"Churchill","year":"2021","journal-title":"Am J Health Econ"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"126842","DOI":"10.1016\/j.vaccine.2025.126842","article-title":"The affordable care act and change in human papillomavirus (HPV) vaccine uptake in the United States","volume":"50","author":"Gao","year":"2025","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1370\/afm.1542","article-title":"Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience","volume":"11","author":"Goad","year":"2013","journal-title":"Ann Fam Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1080\/21645515.2019.1602433","article-title":"Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states","volume":"15","author":"Calo","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/21645515.2019.1637218","article-title":"The essential role of pharmacists facilitating vaccination in older adults: the case of herpes zoster","volume":"16","author":"Tak","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1016\/j.vaccine.2019.08.060","article-title":"Pharmacist role in vaccination: evidence and challenges","volume":"37","author":"Poudel","year":"2019","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/IPRP.S63822","article-title":"The role of community pharmacy-based vaccination in the USA: current practice and future directions","volume":"4","author":"Bach","year":"2015","journal-title":"Integr Pharm Res Pract"},{"key":"ref22","volume-title":"States of health: Pharmacist vaccination laws and reaching CDC goals on HPV: Vital Record, Texas A&M Health","author":"Mitchell","year":"2018"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0033354917742117","article-title":"Authority of Pharmacists to administer human papillomavirus vaccine: alignment of state Laws with age-level recommendations","volume":"133","author":"Dingman","year":"2018","journal-title":"Public Health Rep"},{"key":"ref24","volume-title":"Pharmacist Administred Vaccines: National Alliance of State Pharmacy Associations","year":"2023"},{"key":"ref25","volume-title":"Pharmacist Authority to Administer Vaccines by State","year":"2019"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/eurpub\/ckad232","article-title":"Understanding the health system barriers and enablers to childhood MMR and HPV vaccination among disadvantaged, minority or underserved populations in middle- and high-income countries: a systematic review","volume":"34","author":"Essa-Hadad","year":"2024","journal-title":"Eur J Pub Health"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3390\/vaccines9111360","article-title":"Pharmacists' perceived barriers to human papillomavirus (HPV) vaccination: a systematic literature review","volume":"9","author":"Oyedeji","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1016\/j.vaccine.2016.07.056","article-title":"Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents?","volume":"34","author":"Trogdon","year":"2016","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1080\/21645515.2015.1125055","article-title":"Interventions to increase HPV vaccination coverage: a systematic review","volume":"12","author":"Smulian","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ygyno.2013.12.020","article-title":"Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention","volume":"132","author":"Brewer","year":"2014","journal-title":"Gynecol Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0264-410X(98)00131-5","article-title":"Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals","volume":"16","author":"Grabenstein","year":"1998","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/archpedi.153.7.748","article-title":"Impact of North Carolina's universal vaccine purchase program by children's insurance status","volume":"153","author":"Freed","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1016\/j.vaccine.2018.05.103","article-title":"Examination of universal purchase programs as a driver of vaccine uptake among US states, 1995-2014","volume":"36","author":"Mulligan","year":"2018","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"101243","DOI":"10.1016\/j.lana.2025.101243","article-title":"Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity","volume":"51","author":"Zeitouni","year":"2025","journal-title":"Lancet Reg Health Am"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15585\/mmwr.mm7430a1","article-title":"Vaccination coverage among adolescents aged 13-17 years\u2014national immunization survey-teen, United States, 2024","volume":"74","author":"Pingali","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref36","article-title":"Maine revised statutes annotated. \u00a71066. Universal childhood immunization program","year":"2026"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"102480","DOI":"10.1016\/j.jhealeco.2021.102480","article-title":"How important is the structure of school vaccine requirement opt-out provisions? Evidence from Washington, DC's HPV vaccine requirement","volume":"78","author":"Churchill","year":"2021","journal-title":"J Health Econ"},{"key":"ref38","article-title":"Recovering routine immunization rates \u2014 state strategies to move beyond COVID-19 National Academy for State Health Policy (NASHP)","author":"Fiscus","year":"2022"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1370\/afm.2990","article-title":"Reimbursement for HPV vaccine cost in the private sector: a comparison across specialties","volume":"21","author":"Zhu","year":"2023","journal-title":"Ann Fam Med"},{"key":"ref40","volume-title":"KV Informational Packet","year":"2020"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e20193557","DOI":"10.1542\/peds.2019-3557","article-title":"Trends in human papillomavirus vaccination in commercially insured children in the United States","volume":"146","author":"Chen","year":"2020","journal-title":"Pediatrics"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e2023064692","DOI":"10.1542\/peds.2023-064692","article-title":"Policy approaches for increasing adolescent HPV vaccination coverage: a systematic review","volume":"153","author":"McKeithen","year":"2024","journal-title":"Pediatrics"},{"key":"ref43","volume-title":"Exemptions Permitted for State Childcare and School (K\u201312) Immunization Requirements: Immunize.org","year":"2024"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1177\/0033354916663184","article-title":"Human papillomavirus and mandatory immunization Laws: what can we learn from early mandates?","volume":"131","author":"Barraza","year":"2016","journal-title":"Public Health Rep"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/003335490812300617","article-title":"Childhood vaccine and school entry laws: the case of HPV vaccine","volume":"123","author":"Stewart","year":"2008","journal-title":"Public Health Rep"},{"key":"ref46","volume-title":"HPV (Human Papillomavirus) Vaccine Requirements for Secondary School: Immunize.org","year":"2025"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1080\/21645515.2016.1161460","article-title":"Current initiatives to protect Rhode Island adolescents through increasing HPV vaccination","volume":"12","author":"Washburn","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e62519","DOI":"10.7759\/cureus.62519","article-title":"Implementing a school-entry mandate for the human papillomavirus vaccine: benefits and challenges","volume":"16","author":"Alzahrani","year":"2024","journal-title":"Cureus"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1080\/21645515.2016.1150394","article-title":"Impact of school-entry and education mandates by states on HPV vaccination coverage: analysis of the 2009-2013 National Immunization Survey-Teen","volume":"12","author":"Perkins","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"752.e1","DOI":"10.1016\/j.ajog.2016.03.022","article-title":"Rates of human papillomavirus vaccine uptake amongst girls five years after introduction of statewide mandate in Virginia","volume":"214","author":"Cuff","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1056\/NEJMsr1003547","article-title":"HPV vaccination mandates \u2014 lawmaking amid political and scientific controversy","volume":"363","author":"Colgrove","year":"2010","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1089\/jwh.2016.5869","article-title":"Impact of Virginia's school-entry vaccine mandate on human papillomavirus vaccination among 13-17-year-old females","volume":"26","author":"Pierre-Victor","year":"2017","journal-title":"J Womens Health (Larchmt)"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/15265160701429599","article-title":"Public health, public trust and lobbying","volume":"7","author":"Wynia","year":"2007","journal-title":"Am J Bioeth"},{"key":"ref54","volume-title":"School and Day Care Minimum Immunization Requirements 2025","year":"2026"},{"key":"ref55","article-title":"Human papillomavirus (HPV) vaccination: information for health care providers 2021","year":"2021"},{"key":"ref56","first-page":"61","article-title":"National human papillomavirus vaccination coverage among adolescents aged 13-17 years-National Immunization Survey--teen, United States, 2011","volume":"63","author":"Curtis","year":"2014","journal-title":"MMWR Suppl"},{"key":"ref57","first-page":"625","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013","volume":"63","author":"Elam-Evans","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1080\/21645515.2016.1145316","article-title":"New initiatives to improve HPV vaccination rates","volume":"12","author":"Palfrey","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"850","DOI":"10.15585\/mmwr.mm6533a4","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years\u2014United States, 2015","volume":"65","author":"Reagan-Steiner","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1542\/peds.2011-2641","article-title":"Middle school vaccination requirements and adolescent vaccination coverage","volume":"129","author":"Bugenske","year":"2012","journal-title":"Pediatrics"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1257\/pol.20170067","article-title":"Direct and spillover effects of middle school vaccination requirements","volume":"11","author":"Carpenter","year":"2019","journal-title":"Am Econ J Econ Policy"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ypmed.2010.12.010","article-title":"Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines","volume":"52","author":"Dempsey","year":"2011","journal-title":"Prev Med"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.socscimed.2016.04.030","article-title":"Collaborative patient-provider communication and uptake of adolescent vaccines","volume":"159","author":"Moss","year":"2016","journal-title":"Soc Sci Med"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"E524","DOI":"10.9778\/cmajo.20180191","article-title":"Impact of school vaccination mandates on pediatric vaccination coverage: a systematic review","volume":"7","author":"Greyson","year":"2019","journal-title":"CMAJ Open"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/jamapediatrics.2020.1852","article-title":"Association between human papillomavirus vaccination school-entry requirements and vaccination initiation","volume":"174","author":"Ko","year":"2020","journal-title":"JAMA Pediatr"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/JXX.0000000000000142","article-title":"Policy support for expanding the adolescent vaccine school mandate in Pennsylvania to include the human papillomavirus (HPV) vaccine","volume":"31","author":"Falik","year":"2019","journal-title":"J Am Assoc Nurse Pract"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2105\/AJPH.2014.301910","article-title":"Adolescent immunization coverage and implementation of new school requirements in Michigan, 2010","volume":"104","author":"Potter","year":"2014","journal-title":"Am J Public Health"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jadohealth.2021.07.020","article-title":"National and state-level composite completion of recommended vaccines among adolescents in the United States, 2015-2018","volume":"69","author":"La","year":"2021","journal-title":"J Adolesc Health"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMp078054","article-title":"Politics, parents, and prophylaxis \u2014 mandating HPV vaccination in the United States","volume":"356","author":"Charo","year":"2007","journal-title":"N Engl J Med"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1750-8606.2008.00071.x","article-title":"Effective curriculum-based sex and STD\/HIV education programs for adolescents","volume":"3","author":"Kirby","year":"2009","journal-title":"Child Dev Perspect"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12889-019-6566-y","article-title":"Going beyond the individual: how state-level characteristics relate to HPV vaccine rates in the United States","volume":"19","author":"Franco","year":"2019","journal-title":"BMC Public Health"},{"key":"ref72","volume-title":"State Non-Medical Exemptions From School Immunization Requirements: National Conference of State Legislatures","year":"2026"},{"key":"ref73","year":""},{"key":"ref74","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/17437199.2016.1240625","article-title":"A comprehensive review of reviews of school-based interventions to improve sexual-health","volume":"11","author":"Denford","year":"2017","journal-title":"Health Psychol Rev"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"2309752","DOI":"10.1080\/23311908.2024.2309752","article-title":"Assessing the role of school-based sex education in sexual health behaviours: a systematic review","volume":"11","author":"Niland","year":"2024","journal-title":"Cogent Psychol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/00333549221081821","article-title":"Knowledge of human papillomavirus and cervical Cancer among low-income women in New Jersey","volume":"138","author":"Silvera","year":"2023","journal-title":"Public Health Rep"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"e74023","DOI":"10.7759\/cureus.74023","article-title":"Bridging the gap: enhancing HPV (human papillomavirus) education to combat rising Cancer rates","volume":"16","author":"Sood","year":"2024","journal-title":"Cureus."},{"key":"ref78","volume-title":"Relationships and Sexuality Education (RSE) in Primary and Post-Primary Irish Schools","author":"Keating","year":"2018"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40258-016-0225-6","article-title":"The role of physician recommendations and public policy in human papillomavirus vaccinations","volume":"14","author":"Moghtaderi","year":"2016","journal-title":"Appl Health Econ Health Policy"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2105\/AJPH.2017.304263","article-title":"A qualitative comparative analysis of combined state health policies related to human papillomavirus vaccine uptake in the United States","volume":"108","author":"Roberts","year":"2018","journal-title":"Am J Public Health"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1016\/s2468-2667(20)30139-0","article-title":"Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey","volume":"5","author":"Sonawane","year":"2020","journal-title":"Lancet Public Health"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s12026-016-8890-y","article-title":"HPV and systemic lupus erythematosus: a mosaic of potential crossreactions","volume":"65","author":"Segal","year":"2017","journal-title":"Immunol Res"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12026-016-8815-9","article-title":"Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database","volume":"65","author":"Geier","year":"2017","journal-title":"Immunol Res"},{"key":"ref84","volume-title":"Outreach to Parents","year":"2024"},{"key":"ref85","year":""},{"key":"ref86","volume-title":"Minor Consent Laws for Vaccinations by State","year":"2020"},{"key":"ref87","volume-title":"New York Codes, Rules and Regulations, Title 10, Section 23.4\u2014Minors","year":""},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1080\/21645515.2017.1325980","article-title":"Adolescent human papillomavirus vaccination in the United States: opportunities for integrating pharmacies into the immunization neighborhood","volume":"13","author":"Fava","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1016\/j.vaccine.2017.07.028","article-title":"Primary care team- and clinic level factors affecting HPV vaccine uptake","volume":"35","author":"Chuang","year":"2017","journal-title":"Vaccine"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/j.acap.2017.09.002","article-title":"Human papillomavirus vaccine coverage and prevalence of missed opportunities for vaccination in an integrated healthcare system","volume":"18","author":"Irving","year":"2018","journal-title":"Acad Pediatr"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.vaccine.2016.11.018","article-title":"Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 pillars\u2122 practice transformation program","volume":"35","author":"Zimmerman","year":"2017","journal-title":"Vaccine"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jnma.2019.06.004","article-title":"A \"sense\"-ational HPV vaccination quality improvement project in a family medicine residency practice","volume":"111","author":"McGaffey","year":"2019","journal-title":"J Natl Med Assoc"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3122\/jabfm.2013.03.130102","article-title":"Communities of solution: partnerships for population health","volume":"26","author":"Griswold","year":"2013","journal-title":"J Am Board Fam Med"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/nur.22135","article-title":"A systematic review of human papillomavirus vaccination among US adolescents","volume":"44","author":"Mansfield","year":"2021","journal-title":"Res Nurs Health"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ypmed.2017.08.016","article-title":"\"My mom said it wasn't important\": a case for catch-up human papillomavirus vaccination among young adult women in the United States","volume":"105","author":"Thompson","year":"2017","journal-title":"Prev Med"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1080\/21645515.2018.1467203","article-title":"Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States","volume":"14","author":"Adjei Boakye","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2105\/AJPH.2011.300600","article-title":"Health care provider recommendation, human papillomavirus vaccination, and race\/ethnicity in the US National Immunization Survey","volume":"103","author":"Ylitalo","year":"2013","journal-title":"Am J Public Health"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.4161\/hv.25823","article-title":"Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines","volume":"9","author":"Gargano","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/olq.0b013e3181f12dbf","article-title":"Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area","volume":"38","author":"Brewer","year":"2011","journal-title":"Sex Transm Dis"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.socscimed.2009.05.024","article-title":"Parents' health beliefs and HPV vaccination of their adolescent daughters","volume":"69","author":"Reiter","year":"2009","journal-title":"Soc Sci Med"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.vaccine.2009.12.063","article-title":"Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation","volume":"29","author":"Rosenthal","year":"2011","journal-title":"Vaccine"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ypmed.2015.10.007","article-title":"Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: findings from a provider survey, 2012","volume":"81","author":"Berkowitz","year":"2015","journal-title":"Prev Med"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1542\/peds.2009-3500","article-title":"Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure","volume":"126","author":"Daley","year":"2010","journal-title":"Pediatrics"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1016\/j.vaccine.2012.02.034","article-title":"Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of children's health","volume":"30","author":"Lau","year":"2012","journal-title":"Vaccine"},{"key":"ref105","article-title":"Basic information about HPV and Cancer","year":"2024"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1016\/j.vaccine.2011.02.045","article-title":"Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race\/ethnicity among female students at a New York state university, 2010","volume":"29","author":"Bednarczyk","year":"2011","journal-title":"Vaccine"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/01.OLQ.0000130533.53987.78","article-title":"Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic","volume":"31","author":"Samoff","year":"2004","journal-title":"Sex Transm Dis"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00000441-200403000-00001","article-title":"The association of sociodemographic factors and patient attitudes on influenza vaccination rates in older persons","volume":"327","author":"Chi","year":"2004","journal-title":"Am J Med Sci"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"106554","DOI":"10.1016\/j.ypmed.2021.106554","article-title":"Provider communication and HPV vaccine uptake: a meta-analysis and systematic review","volume":"148","author":"Oh","year":"2021","journal-title":"Prev Med"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"126467","DOI":"10.1016\/j.vaccine.2024.126467","article-title":"Documenting human papillomavirus vaccine refusal among adolescents in electronic health records: a mixed methods study","volume":"42","author":"Vielot","year":"2024","journal-title":"Vaccine"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/1468-0009.12342","article-title":"Impact of pharmacists on access to vaccine providers: a geospatial analysis","volume":"96","author":"Shah","year":"2018","journal-title":"Milbank Q"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1810845\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:51:57Z","timestamp":1776703917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1810845\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":111,"alternative-id":["10.3389\/fpubh.2026.1810845"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1810845","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1810845"}}